New York - A single IV injection of anti-IL-12 antibody, even at low doses, resulted in significant improvement in PASI scores, according to results of a study presented at the recent International Psoriasis Symposium, held here.
Addressing Disparities in Skin-Aging Prevention Among Women of Color
The Cutaneous Connection: Make Data-Driven Decisions For Personalized AD Treatment
Upadacitinib Outperforms Dupilumab in Primary and Secondary End Points in Head-to-Head AD Study
ReV Up Your Vitiligo Treatment Strategies
Seemal Desai, MD, Responds to Study Suggesting Melanoma is Overdiagnosed in White Patients
Federal Trade Commission Votes to Ban Noncompete Clauses Between Employers and Workers